Planet Labs (NYSE: PL) shares are trading higher in Monday's after-hours session after the company reported better-than-expected financial results and raised guidance.
Agenus (NASDAQ: AGEN) has initiated Phase 2 ACTIVATE trials of botensilimab to advance globally in metastatic patients who have progressed on available therapies.
This global Phase 2 program include clinical trials of ACTIVATE-Colorectal and ACTIVATE-Melanoma studies.
Last week, analysts spoke with C3.ai, Inc (NYSE: AI) management at the AI Defense Forum. They listened to speakers from the U.S. Department of Defense and industry consultants regarding the need to speed up deployments of AI to position the U.S. against its adversaries better.
Galaxy Digital Holdings (OTC: BRPHF) founder and CEO Mike Novogratz has claimed to have heard that Fidelity Investments will "shift retail customers into crypto soon," according to a Bloomberg report.
The shares of oncology-focused Ideaya Biosciences Inc (NASDAQ: IDYA) are trading higher after interim data from its solid tumor candidate darovasertib with cancer…
Even though the Inflation Reduction Act of 2022 is in effect, markets can have a way of determining whether the plan works or not. Not that it’s expected, but if the oil and natural gas markets become even more volatile than they are — with Russia and Europe at odds — it’s a concern if you’re thinking about the possibilities of higher prices.
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.